Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

K. D. Cummins, S. M. Jane, S. Nikovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Article numbere237
JournalBlood Cancer Journal
Volume4
Issue number8
DOIs
Publication statusPublished - 2014

Cite this

Cummins, K. D. ; Jane, S. M. ; Nikovic, S. ; Bazargan, Ali ; Filshie, Robin J A ; Sutrave, G ; Hertzberg, Mark ; Scott, A. ; Lane, S. ; Yannakou, C. K. ; Ritchie, Peter D. ; D'Rozario, J. ; Black, J. ; Bavishi, Ketan ; Wei, A. / Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia. In: Blood Cancer Journal. 2014 ; Vol. 4, No. 8.
@article{9135a560de9b4d65abb3367a13762bdf,
title = "Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia",
author = "Cummins, {K. D.} and Jane, {S. M.} and S. Nikovic and Ali Bazargan and Filshie, {Robin J A} and G Sutrave and Mark Hertzberg and A. Scott and S. Lane and Yannakou, {C. K.} and Ritchie, {Peter D.} and J. D'Rozario and J. Black and Ketan Bavishi and A. Wei",
year = "2014",
doi = "10.1038/bcj.2014.59",
language = "English",
volume = "4",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "8",

}

Cummins, KD, Jane, SM, Nikovic, S, Bazargan, A, Filshie, RJA, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, CK, Ritchie, PD, D'Rozario, J, Black, J, Bavishi, K & Wei, A 2014, 'Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia' Blood Cancer Journal, vol. 4, no. 8, e237. https://doi.org/10.1038/bcj.2014.59

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia. / Cummins, K. D.; Jane, S. M.; Nikovic, S.; Bazargan, Ali; Filshie, Robin J A; Sutrave, G; Hertzberg, Mark; Scott, A.; Lane, S.; Yannakou, C. K.; Ritchie, Peter D.; D'Rozario, J.; Black, J.; Bavishi, Ketan; Wei, A.

In: Blood Cancer Journal, Vol. 4, No. 8, e237, 2014.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

AU - Cummins, K. D.

AU - Jane, S. M.

AU - Nikovic, S.

AU - Bazargan, Ali

AU - Filshie, Robin J A

AU - Sutrave, G

AU - Hertzberg, Mark

AU - Scott, A.

AU - Lane, S.

AU - Yannakou, C. K.

AU - Ritchie, Peter D.

AU - D'Rozario, J.

AU - Black, J.

AU - Bavishi, Ketan

AU - Wei, A.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84906854162&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.59

DO - 10.1038/bcj.2014.59

M3 - Letter

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 8

M1 - e237

ER -